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Background
HIV-specific cellular immune responses have been
detected in some uninfected infants born to HIV-infected
women, indicating transient virus exposure or replication
has occurred. Small quantities of maternal blood pass into
the infant's circulation during childbirth, termed “micro-
transfusion”, potentially facilitating viral exposure. We
sought to determine the occurrence of microtransfusion
and HIV-specific immune responses as an indicator of
viral exposure in a cohort of uninfected infants born to
HIV-infected women, in the context of interventions.
Materials and methods
46 uninfected infants born to HIV-infected women were
included in this study. Infants were grouped according to
interventions utilised by the mother: none or antiretrovi-
ral therapy (ART; group A, n = 16), ART with elective cae-
sarean section (elCS; group B, n = 12), highly active
antiretroviral therapy (HAART) only (group C, n = 7), and
HAART with elCS (group D, n=11). HLA-A and -B alleles
were typed for all mother-baby pairs to identify the non-
inherited maternal alleles (NIMA). To detect microtrans-
fusion, sensitive flow cytometry and qPCR-based assays
specific for the NIMA were developed and applied to
umbilical cord blood and peripheral blood collected from
HIV-uninfected infants born to HIV-infected women.
HIV-specific immune responses were detected using the
chromium51-release and IFN-γ ELISpot assays.
Results
Microtransfusion was detected in the umbilical cord
blood of 10 of 11 infants tested, and remained detectable
in the peripheral blood of 4 of the 10 infants up to 1 week
of age. 10 of 46 infants had HIV-specific cellular immune
responses, 7 were in group A, 2 in group B, and 1 in group
C, while no infants in group D had detectable responses
(p = 0.02, Fisher's exact test). Blood samples from 3 of
these 10 infants were available for the analysis of micro-
transfusion. Microtransfused maternal cells were present
in the umbilical cord blood of all 3 infants, and remained
in the peripheral blood of 1 infant up to one week of age.
The remaining 7 infants with microtransfusion did not
have detectable HIV-specific immune responses.
Conclusions
In this study, the number of infants with detectable HIV-
specific immune responses decreases with the use of
MTCT interventions, suggesting that these interventions
reduce viral exposure in these infants. This is the first
study to observe both microtransfusion and HIV-specific
immune responses in uninfected infants, indicating that
the passage of maternal blood may be a source of viral
exposure and subsequent development of potentially pro-
tective HIV-specific immune responses in infants born to
HIV-infected women.
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